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Bicyclic Guanidine Libraries
A novel method for the solid-phase synthesis of bicyclic guanidines has been described in a
recent publication (J.M. Ostresh et al., J. Org. Chem., 63, (1998), 8622-8623). Following the
preparation of acylated dipeptides (1) on methylbenzhydrylamine-derivatised polystyrene resin,
exhaustive reduction using borane-THF generated triamines that could be cyclised using
thiocarbonyldiimidazole. The product bicyclic guanidines (2) could be cleaved from the resin
beads by treatment with hydrogen fluoride, although there was evidence that the products
could also be cleaved with 100% trifluoroacetic acid. Steric factors had a key effect on the
cyclisation step: aminoisobutyric acid in the R1 position led to complete cyclisation, whilst in
the R2 position, cyclisation was inhibited.
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Guanidines are a common functionality in pharmacologically active compounds where their
cationic nature is responsible for strong binding to negatively charged regions of target
proteins. With three positions of variation, the synthetic approach above can generate large
numbers of library products. The methodology was used to generate a combinatorial library
using the positional scanning format using predetermined isokinetic ratios of the amino acid
and carboxylic acid monomers. The products are currently being used to identify antibacterial
and opioid receptor ligands.
--------------------------------------------------------------------------------------------------------------
Flavone Benzodiazepine Receptor Ligands
A number of naturally-occurring flavonoids, in addition to the flavone nucleus itself, are
known to be ligands of the central benzodiazepine receptors (BDZ-Rs). Synthetically-modified
derivatives with electron-deficient groups exhibit even higher affinity for the BDZ-Rs and have
potent anxiolytic activity. An approach to small solution-phase libraries of flavone derivatives
has been described (M. Marder et al., Biochem. Biophys. Res. Comm., 249, (1998), 481-485).
The library of 36 flavone derivatives (3) were made by the solution reaction of mixtures of
four 2’-hydroxyacetophenones with each of nine benzoyl chlorides. The mixtures of four
products generated were separated by HPLC before screening against the BDZ-Rs.
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The compounds were screened against BDZ-Rs in cerebral cortex that contains approximately
equal proportions of both type I and II receptors. More active compounds were also tested
against cerebellar membranes that are enriched in the type I BDZ-R. Of the library screened,
one compound (R = 3-Br, X = Br) had a Ki value of 19 nM. Preliminary pharmacological
experiments in mice demonstrated that this compound had anxiolytic activity without
depressant effects following i.p. administration at 0.1 and 0.3 mg/kg.
--------------------------------------------------------------------------------------------------------------
Multi-target libraries
Increasingly the design of combinatorial libraries has attempted to generate as diverse a set of
compounds as possible with the intention of maximising drug discovery success against a
range of targets. Although the truly universal library may not be readily achievable, recent
libraries have attempted to target several biological targets simultaneously. A recent
contribution to this strategy is the preparation of a library that produced inhibitors of both
matrix metalloproteinases (MMPs) and phosphodiesterases (PDEs) (C.J. Burns et al., Angew.
Chem. Int. Ed., 37, (1998), 2848-2850).
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Using either solution or solid-phase chemistry, two structurally related but functionally distinct
β-sulphonyl hydroxamic acid libraries were prepared using as a key reaction the Michael
addition of an aromatic thiol onto an αβ-unsaturated ester. Variation of three regions in the
products allowed the synthesis of an initial library of over 300 products tested against MMP-1,
MMP-2, MMP-3 and PDE4. As an illustration of the selectivity of the products discovered,
the cyclopentane derivative (4) was a selective MMP inhibitor (MMP-2 Ki = 10nM), whilst
the phenylbutyl derivative (5) selectively inhibited PDE4 (IC50 = 1 nM).
